| NCT ID | NCT06610838 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Wisconsin, Madison |
| Condition | Electronic Cigarette Use |
| Study Type | OBSERVATIONAL |
| Enrollment | 600 participants |
| Start Date | 2025-01-06 |
| Primary Completion | 2029-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 600 participants in total. It began in 2025-01-06 with a primary completion date of 2029-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Electronic nicotine delivery systems (ENDS) are used by millions of Americans, however their long-term health effects are unknown. This research proposal will quantify the effects of long-term ENDS use on validated and novel biomarkers of cardiovascular and pulmonary disease and how they are influenced by use heaviness, age, body weight, and co-use of other products. This study will produce the most informative evidence to date on how long-term ENDS use affects cardiovascular and pulmonary health.
Eligibility Criteria
Inclusion Criteria: * greater than or equal to 21 years of age * has vaped a nicotine e-cigarette product at least 2 days/week for most weeks for greater than or equal to 12 months * plans to remain in catchment area for greater than or equal to 3 years * smoked 5 or fewer tobacco cigarettes in the past 6 months * no serious CV, pulmonary, or other medical problems * not currently pregnant * no plans to stop vaping Exclusion Criteria: * serious CV, pulmonary, or other medical problems (e.g., moderate or severe aortic stenosis, class III or IV heart failure, blood pressure greater than or equal to 160/100 mmHg, interstitial lung disease, sarcoidosis, Stage 3 or 4 cancer) * combusted or vaped cannabis use 3 days/week or more in the past 3 months * currently pregnant * not able to read an write English * incarceration
Contact & Investigator
Timothy Baker, PhD
PRINCIPAL INVESTIGATOR
University of Wisconsin, Madison
Frequently Asked Questions
Who can join the NCT06610838 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, studying Electronic Cigarette Use. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06610838 currently recruiting?
Yes, NCT06610838 is actively recruiting participants. Contact the research team at jhs@medicine.wisc.edu for enrollment information.
Where is the NCT06610838 trial being conducted?
This trial is being conducted at Madison, United States.
Who is sponsoring the NCT06610838 clinical trial?
NCT06610838 is sponsored by University of Wisconsin, Madison. The principal investigator is Timothy Baker, PhD at University of Wisconsin, Madison. The trial plans to enroll 600 participants.